老年与高龄脓毒症危重患者死亡的危险因素:前瞻性、观察性、多中心队列研究
本研究为前瞻性、观察性、多中心队列研究,纳入1490例≥65岁脓毒症危重患者,其中82.6%(1231例)存在心血管衰竭。患者分为老年组(65-79岁)和高龄组(≥80岁),总体院内死亡率为48.8%(727例),高龄组显著高于老年组(54.2% vs 47.4%;p=0.02)。老年组中与死亡独立相关的因素为APACHE II评分、脓毒症诊断时患者所在位置、发生急性肾损伤和血小板减少;高龄组中预测院内死亡的因素为年龄、APACHE II评分和及时遵循复苏集束化治疗。
要点
- ≥80岁脓毒症危重患者院内死亡率为54.2%,显著高于65-79岁组的47.4%(p=0.02)。
- 仅在≥80岁组中,年龄是院内死亡的独立危险因素;在65-79岁组中年龄不是独立危险因素。
- ≥80岁组中,及时遵循复苏集束化治疗(6小时内)与院内死亡率降低相关。
- 65-79岁组中,APACHE II评分、脓毒症诊断时患者所在位置、急性肾损伤和血小板减少与死亡独立相关。
- 总体人群中82.6%(1231例)存在心血管衰竭,总体院内死亡率为48.8%(727例)。
适用人群与场景
- 年龄≥65岁的脓毒症危重患者,分为老年组(65-79岁)和高龄组(≥80岁)。
- 研究纳入1490例患者,平均年龄74.5(±5.6)岁,男性876例(58.8%)。
处置流程与药物剂量
- 在≥80岁患者中,及时遵循复苏集束化治疗(6小时内)与院内死亡率降低相关。
研究设计与关键结果
- 研究类型为前瞻性、观察性、多中心队列研究,纳入1490例≥65岁脓毒症危重患者。
- 总体院内死亡率为48.8%(727例),高龄组(≥80岁)为54.2%,老年组(65-79岁)为47.4%,高龄组显著更高(p=0.02)。
- 在65-79岁组中,与死亡独立相关的因素包括APACHE II评分、脓毒症诊断时患者所在位置、发生急性肾损伤和血小板减少。
- 在≥80岁组中,预测院内死亡的因素为年龄、APACHE II评分和及时遵循复苏集束化治疗。
证据类型、等级与局限
- 证据类型:前瞻性、观察性、多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于≥80岁脓毒症危重患者,及时在6小时内遵循复苏集束化治疗与降低院内死亡率相关。
- 年龄≥80岁的脓毒症危重患者院内死亡率较高,年龄是该组独立危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Age has been traditionally considered a risk factor for mortality in elderly patients admitted to intensive care units. The aim of this prospective, observational, multicenter cohort study is to determine the risk factors for mortality in elderly and very elderly critically ill patients with sepsis.
RESULTS: A total of 1490 patients with ≥ 65 years of age were included in the study; most of them 1231 (82.6%) had a cardiovascular failure. The mean age (± SD) was 74.5 (± 5.6) years, and 876 (58.8%) were male. The patients were divided into two cohorts: (1) elderly: 65-79 years and (2) very elderly: ≥ 80 years. The overall hospital mortality was 48.8% (n = 727) and was significantly higher in very elderly compared to elderly patients (54.2% vs. 47.4%; p = 0.02). Factors independently associated with mortality were APACHE II score of the disease, patient location at sepsis diagnosis, development of acute kidney injury, and thrombocytopenia in the group of elderly patients. On the other hand, in the group of very elderly patients, predictors of hospital mortality were age, APACHE II score, and prompt adherence of the resuscitation bundle.
CONCLUSION: This prospective multicenter study found that patients aged 80 or over had higher hospital mortality compared to patients between 65 and 79 years. Age was found to be an independent risk factor only in the very elderly group, and prompt therapy provided within the first 6 h of resuscitation was associated with a reduction in hospital mortality in the very elderly patients.
参考来源
- Martin-Loeches I, Guia MC, Vallecoccia MS, et al. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care. 2019. PMID: 30715638. doi:10.1186/s13613-019-0495-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。